April 11, 2021

glimworm

Advances in world technology

Supernus Up on Report of Development With ADHD Cure

Supernus Pharmaceuticals  (SUPN) – Get Report shares jumped on Wednesday following the drugmaker centered on the central nervous method documented progress in a Phase 3 research of an attention-deficit-hyperactivity-condition drug.